全球藥品商業化解決方案與服務業，2024-2029

Pharmaceutical Commercialization Solutions and Services Industry, Global, 2024-2029

出版日期: 2024年09月10日 | 出版商:

Frost & Sullivan | 英文 89 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

基於SaaS服務平台的創新精準行銷和程序化行銷方式加速醫藥商業化

隨著越來越偏好以患者為中心的醫療保健提供方式，製藥業透過清楚地了解市場相關人員、細分市場和上市後期望並制定無縫的打入市場策略來為市場商業化做好準備。為了應對不斷變化的區域市場狀況，製藥公司與第三方物流合作，採用適應性供應鏈策略，例如雙重採購、庫存和先進的場景規劃，同時降低分銷風險。干擾。因此，行銷和銷售策略目的是幫助製藥公司應對相關人員、監管機構、最終用戶和其他技術供應商的海洋。製藥公司行銷利用科學資料、推薦等在 HCP（醫療保健專業人員）中建立積極的藥物採用率，以提高產品知名度並鼓勵後續藥物的採用，建立積極的形象和信任。製藥公司採取逐步進入商業市場的方法，包括從根據產品的提案主張確定目標市場，到了解不斷變化的最終用戶觀點，以及必須採取必要的改變來保持競爭優勢。自動化和利用人工智慧、機器學習和雲端解決方案將幫助製藥公司擴大商業業務。這些工具使用預測分析來進行市場細分、內容個人化、潛在客戶識別和評分以及隨後的市場進入，確保更好的產品採用率和收益。製藥公司和供應商必須致力於跨產業合作，以提高商業化的成功率。該分析深入探討了 HEOR 解決方案、客製化/精準全通路行銷策略以及付款人和 PBM 的綜合藥品定價的市場機會，並依服務模式/合約類型對預測進行了細分。

With the growing preference for a patient-centric care delivery approach, the pharma industry follows a robust step-by-step approach towards market commercialization, with a clear understanding of the market stakeholders, segments, as well as post-launch forecasts to create seamless go-to-market strategies. To cater to the ever-evolving market landscapes across geographies, pharma companies are collaborating with third-party logistics and adopting adaptive supply chain strategies, such as dual sourcing, stockpiling, and advanced scenario planning, while tapping into established distribution partners' capabilities to avoid distribution risks and disruptions. As a result, marketing and sales strategies are designed to allow pharma companies to navigate the sea of stakeholders, regulatory bodies, end users, and other technology vendors. To increase product awareness and subsequent uptake, pharma marketing creates a positive image and confidence amongst HCPs for drug adoption using scientific data, testimonials, and many more. Pharma companies will have to adopt a step-by-step approach toward commercial market access, which involves everything from identifying the target market based on the product value proposition to understanding changes in end-user perspective and making the necessary alterations to maintain a competitive edge. Automation and the use of AI, ML, and cloud solutions will be instrumental in upscaling pharma commercial operations. These tools use predictive analytics for market segmentation, content personalization, lead identification and scoring, and subsequent market access, thereby ensuring better product uptake and revenue. Pharma companies and vendors must look at industry cross-collaborations that will improve commercialization success. This analysis dives deep into market opportunities available in HEOR solutions, tailormade/precision omnichannel marketing strategies, and integrated drug pricing for payers and PBMs and categorizes forecasts by service model/agreement type.

Growth Environment: Transformation in Pharmaceutical Commercialization Solutions and Services Sector

Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Pharmaceutical Commercial Solutions and Services Industry

Growth Environment: Ecosystem in Pharmaceutical Commercialization Solutions and Services Sector

Scope of Analysis
Market Definition, Scope and Segmentation
Segmentation by Commercial Services Model/Partnership Type
Pharmaceutical Commercial Value Chain-Commercial Analytics Overview
Market Trend Analysis
Growth Drivers
Growth Restraints

Growth Environment: Pharmaceutical Commercial Services

Pharmaceutical Commercial Launch-Primary Operations and Stakeholders involved
Key Aspects of Pharmaceutical Marketing and Sales
Key Aspects of Pharmaceutical Market Access Process
Vendor Ecosystem

Growth Environment: Pharmaceutical Commercial Services

Digital Solutions for Commercialization by Stakeholders
Technology Application across Pharma Commercial Activities
AI Application across the Commercialization Value Chain
Digital Marketing Strategies for Effective Communication
Digital Market Access Strategies
Embracing Digital Transformation for Patient-centric Pharma Commercialization

Growth Environment: Pharmaceutical Commercial Services

Investment Trends
Investment Trends-Technology Acquisition/Partnerships
Investment Trends-Strategic Partnerships
Investment Trends-Mergers & Acquisitions
New Product Launches-Expansions

Growth Environment: Companies to Action (C2A), Pharmaceutical Commercial Solutions and Services Sector

Competitive Environment
Competitor Assessment: Pure Play
Competitor Assessment: CROs/CSOs
Competitor Assessment: Tech Enablers
Competitor Assessment

Growth Opportunity Analysis: Growth Generator in Pharmaceutical Commercial Solutions and Services Sector

Growth Metrics
Forecast Considerations: Approach and Methodology
Forecast Considerations: Limitations and Caveats
Revenue Forecast
Revenue Forecast by Solution/Services Type
Revenue Forecast Analysis
Revenue Forecast By Service Model/Agreement Type
Revenue Forecast Analysis By Service Model/Agreement Type

Growth Opportunity Analysis: Growth Generator in Pharmaceutical Commercial Solutions and Services Industry

Regional Trend Analysis-North America
Regional Trend Analysis-Europe
Regional Trend Analysis-Asia Pacific
Regional Trend Analysis-Other Emerging Markets

Growth Opportunity Universe

Growth Opportunity 1: Multi AI and LLM agents for HEOR Services
Growth Opportunity 2: Integrated Drug Pricing Strategies for PBMs and Payors
Growth Opportunity 3: Innovative Approaches for Precision Marketing and Sales Strategies